Alma íbúðafélag hf. Expands Bond Issuance with AL210926 Issue

Alma íbúðafélag hf. has completed an expansion of its AL210926 bond issue, increasing the total amount to 3.1 million krónur. The bond has a floating interest rate tied to 3-month REIBOR rates with an additional 1.4% interest rate. The maturity date is September 21, 2026, and the issue is secured by general collateral. Acro verðbréf hf. managed the sale and listing of the bonds on Nasdaq Iceland hf.

Embla Medical hf. (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, has recently announced transactions in relation to its ongoing share buyback program. The program, initiated on February 7, 2025, aims to reduce the company’s share capital and adjust its capital structure by distributing capital to shareholders [1].

During the period from June 30 to July 4, 2025, Embla Medical acquired 46,300 shares under the program at an average price of DKK 33.98. The transactions were conducted over five days, with the following details:

- June 30, 2025: 11,500 shares purchased at DKK 33.95
- July 1, 2025: 10,500 shares purchased at DKK 34.00
- July 2, 2025: 9,500 shares purchased at DKK 33.99
- July 3, 2025: 7,400 shares purchased at DKK 34.00
- July 4, 2025: 7,400 shares purchased at DKK 33.99

The total transaction value amounted to DKK 1,573,430. Following these acquisitions, Embla Medical holds 1,659,724 shares, representing 0.39% of the company’s total share capital [1].

The share buyback program is designed to conclude no later than December 31, 2025, but the company has the option to discontinue it at any time. Embla Medical is authorized to purchase up to 2,000,000 shares under the program, corresponding to 0.47% of the current share capital. The total consideration for shares purchased under the program shall not exceed USD 10 million [1].

The program is conducted in accordance with Regulation No. 596/2014 of the European Parliament and of the Council on market abuse ("MAR"), and the Commission’s delegated regulation 2016/1052 [1].

In a separate development, Alma íbúðafélag hf. has completed an expansion of its AL210926 bond issue, increasing the total amount to 3.1 million krónur. The bond features a floating interest rate tied to 3-month REIBOR rates with an additional 1.4% interest rate. The maturity date is September 21, 2026, and the issue is secured by general collateral. Acro verðbréf hf. managed the sale and listing of the bonds on Nasdaq Iceland hf. [2].

References:
[1] https://www.tradingview.com/news/reuters.com,2025-07-07:newsml_Wkr1qnhZF:0-embla-medical-hf-transactions-in-relation-to-share-buyback-program/
[2] https://news.cision.com/embla-medical-hf-/r/embla-medical-hf--transactions-in-relation-to-share-buyback-program%2Cc4204160